Related Experiment Video
Updated: Jul 14, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Stroke prevention using oral anticoagulants among patients with atrial fibrillation: a qualitative study of
S Wright1,2, O Hamed1,2, N Lowres3
1School of Medicine, University of Notre Dame, Sydney, NSW, Australia.
Background:
To examine Australian general practitioners' (GPs) perspectives on initiating oral anticoagulation for stroke prevention in patients with atrial fibrillation, and their approaches to monitoring medication adherence and persistence.
Methods:
This qualitative study used semi-structured interviews with Australian GPs recruited from a large survey of anticoagulation practices. Interviews were conducted online, audio-recorded, transcribed verbatim and analysed using thematic analysis with inductive coding. Analysis was undertaken independently by multiple researchers, with consensus reached through team discussion. Interviews continued until thematic saturation was achieved.
Results:
Fourteen GPs were interviewed. Initial management of atrial fibrillation and oral anticoagulation initiation varied, with limited access to echocardiography and cardiology services identified as key barriers, along with patient bleeding risk. Assessing and monitoring long-term adherence and persistence remained challenging, particularly among patients with low health literacy, cognitive impairment, polypharmacy and financial constraints. GPs used a range of strategies to monitor and improve adherence and persistence, such as patient education, supplemented by recall systems, multidisciplinary input and pharmacist involvement.
Conclusions:
Australian GPs report multiple challenges in initiating and monitoring anticoagulation for atrial fibrillation. Enabling GPs to confidently start oral anticoagulants without delaying for diagnostic testing/cardiology review, improving access to echocardiography services, and supporting GPs to monitor adherence and persistence may help reduce stroke incidence.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
